NYMOX PHARMACEUTICAL CORP's ticker is NYMX and the CUSIP is P73398102. A total of 38 filers reported holding NYMOX PHARMACEUTICAL CORP in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $6,434 | -19.6% | 19,900 | -2.5% | 0.00% | -50.0% |
| Q3 2022 | $8,000 | -38.5% | 20,400 | -30.6% | 0.00% | -33.3% |
| Q2 2022 | $13,000 | -70.5% | 29,400 | -15.2% | 0.00% | -62.5% |
| Q1 2022 | $44,000 | +46.7% | 34,650 | +48.1% | 0.01% | +60.0% |
| Q4 2021 | $30,000 | -53.8% | 23,400 | -25.5% | 0.01% | -58.3% |
| Q3 2021 | $65,000 | -8.5% | 31,400 | -29.7% | 0.01% | -7.7% |
| Q2 2021 | $71,000 | -22.8% | 44,650 | +8.2% | 0.01% | -38.1% |
| Q1 2021 | $92,000 | -14.0% | 41,250 | -4.6% | 0.02% | -22.2% |
| Q4 2020 | $107,000 | -39.5% | 43,250 | -39.7% | 0.03% | -53.4% |
| Q3 2020 | $177,000 | -23.7% | 71,750 | +10.0% | 0.06% | -34.8% |
| Q2 2020 | $232,000 | +39.8% | 65,250 | -8.2% | 0.09% | +17.1% |
| Q1 2020 | $166,000 | +110.1% | 71,060 | +97.4% | 0.08% | +153.3% |
| Q4 2019 | $79,000 | – | 36,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MARATHON CAPITAL MANAGEMENT | 55,000 | $179,000 | 0.09% |
| WEDBUSH SECURITIES INC | 180,945 | $590,000 | 0.09% |
| Brown Advisory Securities, LLC | 28,000 | $91,000 | 0.03% |
| FNY Managed Accounts LLC | 8,000 | $26,080,000 | 0.02% |
| FT Options LLC | 10,000 | $26,000 | 0.02% |
| WEBSTER BANK, N. A. | 40,000 | $130,000 | 0.02% |
| GSA CAPITAL PARTNERS LLP | 30,907 | $101,000 | 0.01% |
| GOFEN & GLOSSBERG LLC /IL/ | 25,000 | $82,000 | 0.00% |
| NATIONAL PLANNING CORP | 11,000 | $32,000 | 0.00% |
| Virtu KCG Holdings LLC | 24,705 | $81,000 | 0.00% |